On September 21, 2024, the ANABIO Spobiotic Research Center (ANABIO R&D) had the honor of welcoming Mr. Lukasz – an investor from Mekong Capital – to visit its Center.
During the visit, Mr. Lukasz was briefed by the R&D specialists at the Center on the research and development processes, as well as the outstanding efficacy of the probiotic products currently in development. These results, validated through clinical trials, not only confirm the quality of the products but also stand as evidence of the company’s commitment to delivering breakthrough, reliable health solutions.
Mr. Lukasz highly appreciated the efforts and achievements of the Center’s staff, and expressed strong confidence in the company’s potential to shape the probiotic market in Vietnam. He also offered strategic recommendations for upgrading infrastructure and expanding the research center to position the company as an internationally recognized biotech enterprise. According to Mr. Lukasz, with its bold direction and long-term vision, the company has the potential to become a “tech unicorn” – directly competing with the world’s leading bioproduct corporations. Mr. Lukasz’s visit underscores the company’s growing appeal on the international stage and provides strong motivation for continued investment in research and development. This support reinforces the company’s mission to elevate the LiveSpo brand of probiotics globally, accompanying consumers worldwide on their journey toward comprehensive health protection
Here are a few images from the visit:
